Prudential Financial’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-278
Closed -$233K 2644
2021
Q3
$233K Buy
278
+11
+4% +$11.2K ﹤0.01% 2427
2021
Q2
$339K Buy
267
+16
+6% +$18.1K ﹤0.01% 2261
2021
Q1
$275K Buy
251
+30
+14% +$39.6K ﹤0.01% 2303
2020
Q4
$316K Buy
+221
New +$236K ﹤0.01% 2229

Other funds holding CDLX

Prudential Financial's CDLX Position: Q4 2021 in Review

Prudential Financial sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 278 shares — an estimated $233K sold.

Prudential Financial first reported a position in CDLX in Q4 2020 and held it in 4 quarters. The position peaked at $339K in Q2 2021. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

  • Prudential Financial reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
  • Prudential Financial sold 278 Cardlytics shares in Q4 2021, an estimated $233K.
  • Prudential Financial first reported a position in Cardlytics in Q4 2020 and held it in 4 quarters.
  • Prudential Financial's Cardlytics position peaked at $339K in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on Prudential Financial's 13F filing for Q4 2021, filed 14 Feb 2022.